Centessa Pharmaceuticals PLC ADREigentümerstruktur
| Preis (2024-04-19) | 52W Hoch | 52W Tief |
| 10.57 USD | 12,45 USD | 3,96 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 8,8 USD | 4 | 1 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 100.306.000 | 2,35 | 8,43 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Centessa Pharmaceuticals PLC ADR
Mitarbeiter 76
Handelsplatz NASDAQ
Ticker Symbol CNTA
IPO Datum 2021-05-28
Adresse 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT
Webseite https://www.centessa.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Saurabh Saha M.D., Ph.D. | CEO & Director |
| 2 | Dr. David M. Chao Ph.D. | Chief Administrative Officer |
| 3 | Dr. Antoine Yver M.D., M.Sc. | Executive VP & Chairman of Development |
| 4 | Dr. Gregory M. Weinhoff M.B.A., M.D. | Principal Accounting Officer & CFO |
| 5 | Ms. Tia L. Bush | Chief Technology & Quality Officer |
| 6 | Ms. Kristen K. Sheppard Esq., J.D. | Senior Vice President of Investor Relations & Corporate Communications |
| 7 | Mr. Iqbal J. Hussain L.L.B. | General Counsel, Chief Compliance Officer & Corporate Secretary |
| 8 | Ms. Karen M. Anderson | Chief People Officer |
| 9 | Dr. Harris L. Rotman Ph.D. | Senior Vice President of Regulatory Affairs |
| 10 | Dr. Patrick Yue M.D. | Senior VP of Clinical Development & Innovative Medicines |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Medicxi Ventures Management (Jersey) Ltd | 0,00% | 0,00 Mio. USD |
| 2 | General Atlantic Llc | 0,00% | 0,00 Mio. USD |
| 3 | Bvf Inc | 0,00% | 0,00 Mio. USD |
| 4 | EcoR1 Capital, LLC | 0,00% | 0,00 Mio. USD |
| 5 | Vida Ventures Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 6 | OUP Management Co., LLC | 0,00% | 0,00 Mio. USD |
| 7 | Adage Capital Partners Gp LLC | 0,00% | 0,00 Mio. USD |
| 8 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 9 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 10 | TCG Crossover Management, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Point72 Asset Management, L.P. | 0,00% | 0,00 Mio. USD |
| 12 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 13 | Franklin Resources Inc | 0,00% | 0,00 Mio. USD |
| 14 | Artal Group S A | 0,00% | 0,00 Mio. USD |
| 15 | American Century Companies Inc | 0,00% | 0,00 Mio. USD |
| 16 | Affinity Asset Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 17 | Tanager Wealth Management LLP | 0,00% | 0,00 Mio. USD |
| 18 | Cormorant Asset Management, LLC | 0,00% | 0,00 Mio. USD |
| 19 | Octagon Capital Advisors LP | 0,00% | 0,00 Mio. USD |
| 20 | Kynam Capital Management, LP | 0,00% | 0,00 Mio. USD |